LONDON, Muharram 13, 1436, November 06, 2014, SPA -- The Europe Union and drugmakers pledged on Thursday to invest 280 million euros ($350 million) into Ebola research, with the lion's share going to fast-track the testing and manufacture of potential vaccines, Reuters reported. The funding will go to projects backed by the Innovative Medicines Initiative (IMI), a public-private scheme jointly paid for by the European Commission and the pharmaceuticals industry. The final document setting out the plans commits the European Commission to giving up to 140 million euros, with companies providing an equivalent amount in staff time, goods and services. "The EU is determined to help find a solution to Ebola. We are putting our money where our mouth is and boosting EU research on Ebola with an additional 280 million euros," said Carlos Moedas, European Commissioner for research. --SPA 14:54 LOCAL TIME 11:54 GMT www.spa.gov.sa/w